. me, in fact, when i finished my studies in lebanon and i went to the us, and i worked with bernie carpenterresearch center at the brigman women's hospital and children's hospital and harvard medical school. was in 2001, i became the president of the american society of transplantation, and i came back here to serve my country and to do work in in in our region. the problem is our immune system is designed to reject. an organ if you transplant it, because it's recognized as foreign, and the challenge over many years has been, how do you fool the immune system to recognize this organ as foreign and not rejected? this has been the quest for many, many years including peter who won the nobel prize, and with time we started looking at how does the activation of the immune system occurs? and that led to development and testing and studying several new molecules and agents to try to fool the immune system so they don't reject a transplant. i believe i have maybe 19 20 patents registered internationally of several of these pathways that we studied in order to the main goal was to prevent the reject